Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05684796 · ClinicalTrials.gov registry record · NA

Comparison of Two Pulmonary Embolism Treatments

A NA study, sponsored by Penumbra.

Completed
Registry status
NA
Development phase
100
Enrollment target

NCT05684796: Completed NA study, sponsored by Penumbra.

NCT05684796 is a NA study that has completed, run by Penumbra. The registered enrollment target is 100 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05684796, a NA study, has completed, sponsored by Penumbra.

COMPLETED
Registry status
NA
Development phase
100 participants
Enrollment target

Study Summary

The primary objective of this trial is to evaluate the safety and efficacy of treatment with anticoagulation alone versus anticoagulation and mechanical aspiration thrombectomy with the Indigo Aspiration System for the treatment of intermediate-high risk acute pulmonary embolism (PE).

Primary Outcome

Change in RV/LV ratio at 48 hours on original therapy as assessed by computed tomography pulmonary angiography (CTPA). Negative change values represent a reduction in the ratio of right ventricular to left ventricular diameter, consistent with improvement in right ventricular dilation.

Interventions

  • DRUG Anticoagulation
  • DEVICE mechanical aspiration thrombectomy

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2023-11-27
Est. Completion 2025-09-09
Phase NA
Penumbra

25 total trials

What the finished NCT05684796 record still lists

NCT05684796 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).

The record links to 0 conditions, and to 2 interventions - of which Anticoagulation is the first listed.

NCT05684796 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05684796 about?

NCT05684796 is a clinical study titled "Comparison of Two Pulmonary Embolism Treatments". The primary objective of this trial is to evaluate the safety and efficacy of treatment with anticoagulation alone versus anticoagulation and mechanical aspiration thrombectomy with the Indigo Aspiration System for the treatment of intermediate-high risk acute pulmonary embolism (PE).

What is the current status of trial NCT05684796?

This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2023-11-27. Estimated completion is 2025-09-09.

What interventions are being tested in trial NCT05684796?

The interventions under investigation include: Anticoagulation (DRUG), mechanical aspiration thrombectomy (DEVICE).

Who is sponsoring clinical trial NCT05684796?

This trial is sponsored by Penumbra, which has 25 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT05684796's enrollment target sits among peer trials

100 840th of 2000 higher than 1,081 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05684796, the US trial registry maintained by the National Library of Medicine. NCT05684796 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.